MDS: conservative treatment or chemotherapy, which is better?
Feb 23, 2023
Source: Cainiu Health
Dr. Zhang Heyang
Introduction
MDS refers to myelodysplastic syndromes. Treatment for MDS should be tailored according to different underlying causes. For patients in the low-risk group, chemotherapy and hematopoietic stem cell transplantation are generally not recommended. In contrast, high-risk MDS patients have a poor prognosis and are prone to transformation into acute leukemia, thus requiring intensive treatments including chemotherapy and hematopoietic stem cell transplantation.
MDS refers to myelodysplastic syndromes. Treatment for MDS should be symptom-oriented and based on different underlying causes.
1. Conservative treatment
Some MDS patients have not yet progressed to a severe stage. Under medical guidance, conservative treatment may be adopted, using therapies similar to those for aplastic anemia, such as cytokines to stimulate hematopoiesis, thereby mitigating the adverse effects caused by abnormal blood cell production. Patients with mild disease progression may be managed conservatively.
2. Chemotherapy
Chemotherapy is short for chemical drug therapy, which aims to kill cancer cells using chemotherapeutic agents. It can shrink tumors, control disease progression, relieve tumor-related compression, and often prolong survival or even cure cancer. However, its side effects may be difficult for some patients to tolerate. Chemotherapy is suitable for patients in good general condition and whose tumors are sensitive to chemotherapy. More aggressive chemotherapy may be considered for patients under 40 years of age.
Therefore, chemotherapy and hematopoietic stem cell transplantation are generally not recommended for low-risk group patients. For high-risk MDS patients, the prognosis is poor and there is a high risk of transformation into acute leukemia, requiring intensive treatments including chemotherapy and hematopoietic stem cell transplantation.
